A dose-defining study of sumatriptan suppositories in the acute treatment of migraine

International Journal of Clinical Practice

Volumn 53, Issue 8, 1999, Pages

  Bertin, L ^b   Brion, N ^b   Farkklla M ^b   Gobel H ^b   Wessely, P ^b   Saiers, J ^a  

^a GLAXOSMITHKLINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY DYSFUNCTION; SUPPOSITORY; VERTIGO; VOMITING; WORK CAPACITY;

ADOLESCENT; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; SEROTONIN AGONISTS; SUMATRIPTAN; SUPPOSITORIES; TREATMENT OUTCOME;

EID: 0342904907     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325: 316-321.
2. Cady RK, Wendt JK. Kirchner JF et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265: 2831-2835.
3. Oral Sumatriptan Dose-Defining Study Group. Sumatriplan: an oral dose-defining study. Eur Neurol 1991 ; 31: 300-305.
4. Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 1991; 31: 306-313.
5. Pfaffenrath B, Cunin G, Sjonell G et al. Efficacy and safety of sumatriptan tablets in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache. In press.
6. Ryan R, Elkind A, Baker CC et al. Sumatriptan nasal spray for the acute treatment of migraine; results of two clinical studies. Neurology 1997; 49: 1225-1230.
7. Headache Classification Committee of the International Headache Society. Classification of diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(suppl 7): 19-21.
8. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
9. McCullagh P, Neider J A. Generalised linear models. London: Chapman and Hall, 1983: 101-126.
10. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984:91-111.
11. Pilgrim AJ, Blakeborough P. The clinical efficacy of sumatriptan in the acute treatment of migraine. Rev Contemp Pharmacother 1994; 5: 295-309.
12. Tansey MJB, Pilgrim AJ, Lloyd K. Sumatriptan in the acute treatment of migraine. J Neurol Sci 1993; 114: 109-116.
13. De Boer AG, Moolenaar F, De Leede LGJ, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clin Pharmacokinetics 1982; 7: 285-311.
14. Eckhardt VF, Kanzler G. Remmele W. Anorectal ergotism: another cause of solitary rectal ulcers, Gastroenterology 1986; 91: 1123-1127.